|Bid||36.00 x 1100|
|Ask||37.77 x 1800|
|Day's Range||36.03 - 37.68|
|52 Week Range||29.66 - 55.10|
|Beta (5Y Monthly)||1.72|
|PE Ratio (TTM)||7.38|
|Earnings Date||Mar 08, 2022 - Mar 14, 2022|
|Forward Dividend & Yield||2.50 (7.59%)|
|Ex-Dividend Date||Jun 30, 2022|
|1y Target Est||59.00|
Picking a good retail investment is tricky in today’s environment. Franchise Group offers up a healthy dose of diversification and a good helping of cash.
Activist hedge fund Starboard Value, which had offered to buy Kohl's Corp for roughly $9 billion early this year, slashed its stake in the department store by more than 80% in the second quarter, according to a regulatory filing on Friday evening. Starboard first invested in Kohl's during the first quarter of 2022 and the firm owned 2.59% of the company's stock, making it a top 10 holder. In early January, before takeover talk for Kohl's heated up, the stock traded around $50 a share.
TRC Healthcare, creator of Natural Medicines, an unbiased natural medicines database and research tool, today announced that New Jersey-based retailer The Vitamin Shoppe® is sharing this wealth of information about dietary supplements with consumers through their new partnership. Health Enthusiast associates at The Vitamin Shoppe's over 700 stores across the nation can use the Natural Medicines database to help consumers make informed choices about dietary supplements, without being influenced b